These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7076010)

  • 41. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
    Meyers S; Sacher DB; Taub RN; Janowitz HD
    Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
    Gehlert T; Devergne O; Niedobitek G
    J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
    Jahnsen J; Falch JA; Aadland E; Mowinckel P
    Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
    Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short chain fatty acids in inflammatory bowel disease. The effect of bacterial fermentation of blood.
    Holtug K; Rasmussen HS; Mortensen PB
    Scand J Clin Lab Invest; 1988 Nov; 48(7):667-71. PubMed ID: 3201099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PMN-elastase in assessment of patients with inflammatory bowel disease.
    Andus T; Gross V; Caesar I; Krumm D; Hosp J; Gerok W; Schölmerich J
    Dig Dis Sci; 1993 Sep; 38(9):1638-44. PubMed ID: 8359075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis.
    Kapel N; Meillet D; Favennec L; Magne D; Raichvarg D; Gobert JG
    Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):197-202. PubMed ID: 1525248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
    Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
    Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
    Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum and faecal lysozyme in inflammatory bowel disease.
    Klass HJ; Neale G
    Gut; 1978 Mar; 19(3):233-9. PubMed ID: 631644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The computed tomographic morphology of Crohn's disease and ulcerative colitis].
    Klein HM; Wein B; Adam G; Ruppert D; Günther RW
    Rofo; 1995 Jul; 163(1):9-15. PubMed ID: 7626763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of inflammatory bowel disease in northern France (1988-1990).
    Gower-Rousseau C; Salomez JL; Dupas JL; Marti R; Nuttens MC; Votte A; Lemahieu M; Lemaire B; Colombel JF; Cortot A
    Gut; 1994 Oct; 35(10):1433-8. PubMed ID: 7959201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.
    Podolsky DK; Isselbacher KJ
    J Clin Invest; 1983 Jul; 72(1):142-53. PubMed ID: 6192143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.